HealthTronics' OssaTron Lithotriptor Approvable For Heel Spur Pain - Panel
This article was originally published in The Gray Sheet
Executive Summary
HealthTronics' OssaTron orthopedic lithotriptor should be approved for treatment of plantar fasciitis (heel spurs), rather than the more general indication of chronic heel pain syndrome, FDA's Orthopedic and Rehabilitation Devices Panel suggested.
You may also be interested in...
HealthTronics Plans 300-Patient Postmarket Study Of OssaTron For Heel Pain
HealthTronics is planning a 300-patient, 12-week post-market study of the OssaTron orthopedic lithotriptor for treatment of plantar fasciitis (heel spurs), following FDA approval of the device Oct. 12.
HealthTronics Plans 300-Patient Postmarket Study Of OssaTron For Heel Pain
HealthTronics is planning a 300-patient, 12-week post-market study of the OssaTron orthopedic lithotriptor for treatment of plantar fasciitis (heel spurs), following FDA approval of the device Oct. 12.
HealthTronics OssaTron Lithotripter PMA Submission Planned By Year-End
A premarket approval application for HealthTronics' OssaTron lithotripter for treatment of chronic heel pain due to planar fasciitis should be submitted to FDA by December.